The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Growth Hormone Treatment and Drug Market Research Report 2025
Synopsis
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Global Human Growth Hormone Treatment and Drug market is projected to reach US$ 8422.5 million in 2029, increasing from US$ 4860 million in 2022, with the CAGR of 8.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Growth Hormone Treatment and Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Growth Hormone Treatment and Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent
Segment by Application
Hospitals
Specialty Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Growth Hormone Treatment and Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Global Human Growth Hormone Treatment and Drug market is projected to reach US$ 8422.5 million in 2029, increasing from US$ 4860 million in 2022, with the CAGR of 8.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Growth Hormone Treatment and Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Growth Hormone Treatment and Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent
Segment by Application
Hospitals
Specialty Clinics
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Growth Hormone Treatment and Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Human Growth Hormone Treatment and Drug Market Overview
1.1 Product Overview and Scope of Human Growth Hormone Treatment and Drug
1.2 Human Growth Hormone Treatment and Drug Segment by Type
1.2.1 Global Human Growth Hormone Treatment and Drug Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Solvent
1.3 Human Growth Hormone Treatment and Drug Segment by Application
1.3.1 Global Human Growth Hormone Treatment and Drug Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Other
1.4 Global Human Growth Hormone Treatment and Drug Market Size Estimates and Forecasts
1.4.1 Global Human Growth Hormone Treatment and Drug Revenue 2018-2029
1.4.2 Global Human Growth Hormone Treatment and Drug Sales 2018-2029
1.4.3 Global Human Growth Hormone Treatment and Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Growth Hormone Treatment and Drug Market Competition by Manufacturers
2.1 Global Human Growth Hormone Treatment and Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Growth Hormone Treatment and Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Growth Hormone Treatment and Drug Average Price by Manufacturers (2018-2023)
2.4 Global Human Growth Hormone Treatment and Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Growth Hormone Treatment and Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Growth Hormone Treatment and Drug, Product Type & Application
2.7 Human Growth Hormone Treatment and Drug Market Competitive Situation and Trends
2.7.1 Human Growth Hormone Treatment and Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Growth Hormone Treatment and Drug Players Market Share by Revenue
2.7.3 Global Human Growth Hormone Treatment and Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Growth Hormone Treatment and Drug Retrospective Market Scenario by Region
3.1 Global Human Growth Hormone Treatment and Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Growth Hormone Treatment and Drug Global Human Growth Hormone Treatment and Drug Sales by Region: 2018-2029
3.2.1 Global Human Growth Hormone Treatment and Drug Sales by Region: 2018-2023
3.2.2 Global Human Growth Hormone Treatment and Drug Sales by Region: 2024-2029
3.3 Global Human Growth Hormone Treatment and Drug Global Human Growth Hormone Treatment and Drug Revenue by Region: 2018-2029
3.3.1 Global Human Growth Hormone Treatment and Drug Revenue by Region: 2018-2023
3.3.2 Global Human Growth Hormone Treatment and Drug Revenue by Region: 2024-2029
3.4 North America Human Growth Hormone Treatment and Drug Market Facts & Figures by Country
3.4.1 North America Human Growth Hormone Treatment and Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Growth Hormone Treatment and Drug Sales by Country (2018-2029)
3.4.3 North America Human Growth Hormone Treatment and Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Growth Hormone Treatment and Drug Market Facts & Figures by Country
3.5.1 Europe Human Growth Hormone Treatment and Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Growth Hormone Treatment and Drug Sales by Country (2018-2029)
3.5.3 Europe Human Growth Hormone Treatment and Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Growth Hormone Treatment and Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Human Growth Hormone Treatment and Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Growth Hormone Treatment and Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Growth Hormone Treatment and Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Growth Hormone Treatment and Drug Market Facts & Figures by Country
3.7.1 Latin America Human Growth Hormone Treatment and Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Growth Hormone Treatment and Drug Sales by Country (2018-2029)
3.7.3 Latin America Human Growth Hormone Treatment and Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Growth Hormone Treatment and Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Growth Hormone Treatment and Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Growth Hormone Treatment and Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Growth Hormone Treatment and Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Growth Hormone Treatment and Drug Sales by Type (2018-2029)
4.1.1 Global Human Growth Hormone Treatment and Drug Sales by Type (2018-2023)
4.1.2 Global Human Growth Hormone Treatment and Drug Sales by Type (2024-2029)
4.1.3 Global Human Growth Hormone Treatment and Drug Sales Market Share by Type (2018-2029)
4.2 Global Human Growth Hormone Treatment and Drug Revenue by Type (2018-2029)
4.2.1 Global Human Growth Hormone Treatment and Drug Revenue by Type (2018-2023)
4.2.2 Global Human Growth Hormone Treatment and Drug Revenue by Type (2024-2029)
4.2.3 Global Human Growth Hormone Treatment and Drug Revenue Market Share by Type (2018-2029)
4.3 Global Human Growth Hormone Treatment and Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Growth Hormone Treatment and Drug Sales by Application (2018-2029)
5.1.1 Global Human Growth Hormone Treatment and Drug Sales by Application (2018-2023)
5.1.2 Global Human Growth Hormone Treatment and Drug Sales by Application (2024-2029)
5.1.3 Global Human Growth Hormone Treatment and Drug Sales Market Share by Application (2018-2029)
5.2 Global Human Growth Hormone Treatment and Drug Revenue by Application (2018-2029)
5.2.1 Global Human Growth Hormone Treatment and Drug Revenue by Application (2018-2023)
5.2.2 Global Human Growth Hormone Treatment and Drug Revenue by Application (2024-2029)
5.2.3 Global Human Growth Hormone Treatment and Drug Revenue Market Share by Application (2018-2029)
5.3 Global Human Growth Hormone Treatment and Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Human Growth Hormone Treatment and Drug Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Human Growth Hormone Treatment and Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Human Growth Hormone Treatment and Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck Serono
6.4.1 Merck Serono Corporation Information
6.4.2 Merck Serono Description and Business Overview
6.4.3 Merck Serono Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Serono Human Growth Hormone Treatment and Drug Product Portfolio
6.4.5 Merck Serono Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Human Growth Hormone Treatment and Drug Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Ferring Pharmaceuticals
6.6.1 Ferring Pharmaceuticals Corporation Information
6.6.2 Ferring Pharmaceuticals Description and Business Overview
6.6.3 Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ferring Pharmaceuticals Human Growth Hormone Treatment and Drug Product Portfolio
6.6.5 Ferring Pharmaceuticals Recent Developments/Updates
6.7 GeneScience Pharmaceuticals
6.6.1 GeneScience Pharmaceuticals Corporation Information
6.6.2 GeneScience Pharmaceuticals Description and Business Overview
6.6.3 GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GeneScience Pharmaceuticals Human Growth Hormone Treatment and Drug Product Portfolio
6.7.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.8 Ipsen
6.8.1 Ipsen Corporation Information
6.8.2 Ipsen Description and Business Overview
6.8.3 Ipsen Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ipsen Human Growth Hormone Treatment and Drug Product Portfolio
6.8.5 Ipsen Recent Developments/Updates
6.9 LG Life Sciences
6.9.1 LG Life Sciences Corporation Information
6.9.2 LG Life Sciences Description and Business Overview
6.9.3 LG Life Sciences Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 LG Life Sciences Human Growth Hormone Treatment and Drug Product Portfolio
6.9.5 LG Life Sciences Recent Developments/Updates
6.10 Anhui Anke Biotechnology
6.10.1 Anhui Anke Biotechnology Corporation Information
6.10.2 Anhui Anke Biotechnology Description and Business Overview
6.10.3 Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Anhui Anke Biotechnology Human Growth Hormone Treatment and Drug Product Portfolio
6.10.5 Anhui Anke Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Growth Hormone Treatment and Drug Industry Chain Analysis
7.2 Human Growth Hormone Treatment and Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Growth Hormone Treatment and Drug Production Mode & Process
7.4 Human Growth Hormone Treatment and Drug Sales and Marketing
7.4.1 Human Growth Hormone Treatment and Drug Sales Channels
7.4.2 Human Growth Hormone Treatment and Drug Distributors
7.5 Human Growth Hormone Treatment and Drug Customers
8 Human Growth Hormone Treatment and Drug Market Dynamics
8.1 Human Growth Hormone Treatment and Drug Industry Trends
8.2 Human Growth Hormone Treatment and Drug Market Drivers
8.3 Human Growth Hormone Treatment and Drug Market Challenges
8.4 Human Growth Hormone Treatment and Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
